№ lp_1_2_62657
File format: docx
Character count: 3396
File size: 46 KB
The document is an evaluation form used to assess the effectiveness of a Pediatric PRN training course in areas like pain assessment, management, and leadership skills application.
Note:
Year
Topic:
Pediatric pain management
Document type:
Evaluation form
Target audience:
Healthcare professionals
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2015
Region / City:
United Kingdom
Subject:
Medication management in care homes
Document Type:
Guidance / Good Practice Document
Organization:
Chiltern and Aylesbury Vale CCG
Authors:
Unoma Okoli, Seema Gadhia
Intended Audience:
Care home staff responsible for administering PRN medications
Approval Date:
21 May 2015
Review Date:
May 2018
References:
NICE SC1: 2014; CQC Pharmacy Tip: October 2008; British National Formulary April 2015; CCG Care Homes Guidance
Includes Appendices:
Yes (PRN template and example)
Note:
Year
Topic:
Medication Administration
Document Type:
Guidelines
Target Audience:
Staff in care homes
Year:
2020
Region / City:
Online
Topic:
5G, eMIMO, CLI, PRN, RACS, NTN, REDCAP
Document Type:
Report
Organ / Institution:
3GPP TSG-RAN WG2
Author:
Vice Chairman (ZTE Corporation)
Target Audience:
3GPP members
Period of Validity:
November 2nd - 13th, 2020
Approval Date:
2020-11-03
Date of Amendments:
Not specified
Status:
Ongoing
Time Zone:
UTC
Meeting Dates:
November 2nd - 13th, 2020
End Date:
2020-11-13
Context:
Report summarizing the discussions and plans for various NR R16 and R17 topics, including eMIMO, CLI, PRN, RACS, NTN, and REDCAP, from the 3GPP TSG-RAN WG2 break-out sessions.
Year:
2024
Jurisdiction:
New Jersey
Country:
United States
Region / State:
New Jersey
Subject:
Childhood elevated blood lead levels and public health regulation
Document type:
Proposed rulemaking notice
Issuing agency:
New Jersey Department of Health
Division:
Division of Family Health Services
Branch:
Public Health Services Branch
Program:
Child and Adolescent Health Program
Regulatory code:
N.J.A.C. 8:51
Proposal number:
PRN 2024-050
Authorizing official:
Kaitlan Baston, MD, MSc, DFASAM, Commissioner
Consulting body:
Public Health Council
Legal authority:
N.J.S.A. 26:2-137.2 et seq., particularly N.J.S.A. 26:2-137.7
Public comment deadline:
July 5, 2024
Comment submission office:
Office of Legal and Regulatory Compliance, New Jersey Department of Health
City:
Trenton
Program established:
March 25, 1985
Related program:
Lead Screening Program
Year:
2021
Country:
United Kingdom
Healthcare system:
National Health Service (NHS)
Clinical field:
Palliative Care
Document type:
Drug Administration Chart
Patient name:
Blanche Mouse
Alternative patient example:
Balance Mouse
NHS number:
123 456 7890
Date of birth:
14/07/1935
Allergy status:
Nil known
Prescriber:
K R Yockney
Medications included:
Morphine sulfate; Oxycodone; Haloperidol; Levomepromazine; Midazolam; Hyoscine butylbromide
Routes of administration:
Subcutaneous injection
Prescription type:
PRN (as required) and regular medication
Infusion device:
Syringe pump (CME/BD T34 or BodyGuard T)
Treatment duration example:
24 hours infusion
Dose adjustment guidance:
Included for PRN use and syringe driver medication
Clinical indications:
Pain; Nausea and vomiting; Delirium; Agitation; Restlessness; Respiratory tract secretions; Colic
Document components:
Medication prescription fields, dosage instructions, discontinuation guidance, prescriber signature section, signature sheet for staff
Year:
2023
Region / City:
United States
Topic:
Pediatric Neurology/Neurosurgery Program Evaluation
Document Type:
Survey
Organization:
U.S. News & World Report
Author:
U.S. News & World Report
Target Audience:
Healthcare Providers, Pediatric Neurology/Neurosurgery Programs
Validity Period:
Current Year
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Year
Region / City:
Massachusetts
Theme:
Tuberculosis Risk Assessment
Document Type:
User Guide
Organization / Institution:
Massachusetts Department of Public Health
Target Audience:
Healthcare providers, pediatricians
Year:
2019
Region / city:
Not specified
Theme:
Oncology
Document type:
Clinical Protocol
Authors:
Erin Rudzinski, MD; Bruce Pawel, MD; Armita Bahrami, MD; M. John Hicks, MD
Target audience:
Healthcare professionals involved in pediatric oncology
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
February 2019
Year:
2026
Region / City:
South Carolina
Topic:
Retirement, Healthcare
Document Type:
Senate Resolution
Organization:
South Carolina General Assembly
Author:
South Carolina Senate
Target Audience:
South Carolina Senate Members, Public
Period of Action:
January 21, 2026
Date of Approval:
January 21, 2026
Date of Changes:
N/A
Note:
Year
Year:
2026
Region / City:
USA
Theme:
Pediatric and Congenital Cardiology, Cardiothoracic Surgery
Document Type:
Survey
Organization / Institution:
U.S. News & World Report
Author:
Unknown
Target Audience:
Medical Institutions, Healthcare Professionals
Period of Action:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Year
Topic:
Healthcare
Document Type:
Survey
Target Audience:
Healthcare administrators, Pediatric Endocrinology professionals
Context:
Survey for pediatric endocrinology programs, assessing program details, staffing, services, and certification levels for submission to U.S. News rankings.
Year:
2022
Region / City:
Australia
Subject:
Pharmacology, Pharmaceutical Benefits Scheme (PBS)
Document Type:
Submission
Organization / Institution:
Sanofi-Aventis Australia Pty Ltd
Author:
Not specified
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Not specified
Approval Date:
3 June 2022
Date of Changes:
Not specified
Contextual Description:
A regulatory submission detailing the request for listing of dupilumab in new forms for treating severe atopic dermatitis and uncontrolled severe asthma in pediatric patients under the PBS.
Note:
Year
Document Type:
Survey
Target Audience:
Hospitals with Pediatric Neurology/Neurosurgery Programs
Year:
2021
Region / City:
Global
Topic:
Pediatric HIV Treatment
Document Type:
Guideline
Organization:
World Health Organization (WHO)
Author:
World Health Organization (WHO)
Target Audience:
Healthcare workers, caregivers, HIV service providers, ministries of health
Period of Application:
Ongoing
Approval Date:
2021
Date of Changes:
Not specified
Note:
Year
Theme:
Medical Referral, Dental Treatment
Document Type:
Medical Referral Form
Target Audience:
Healthcare professionals, dentists, pediatricians
Note:
Year
Contextual description:
The document outlines the role and responsibilities of the Clinical Director for Healthy Young Athletes (Pediatric Screening) within the Special Olympics program.